← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2012Last known activity
Feb 20, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT04248803Reponsible party - principal investigatorN/AFeb 20, 2020
- NCT04248803Lead sponsorN/AFeb 20, 2020
- NCT04250519Lead sponsorPhase 1Feb 15, 2020
- NCT04250519Reponsible party - principal investigatorPhase 1Feb 15, 2020
- NCT02234206Reponsible party - principal investigatorPhase 2Dec 1, 2012
- NCT02234206Lead sponsorPhase 2Dec 1, 2012
- NCT01847963CollaboratorN/AJun 1, 2012
- NCT01847963Lead sponsorN/AJun 1, 2012
- NCT01847963Reponsible party - principal investigatorN/AJun 1, 2012
Details
- Last known activity
- Feb 20, 2020